Evidence map›Paper›PMID 42440629›Full record

ArticleFrontiers in medicine2026

Integrated miRNA-mRNA network analysis identifies miR-182-5p as a potential regulator in COPD pathogenesis.

Hannah Burke, Jodie Ackland, Bastian R Angermann, Graham Belfield, Doriana Cellura, Damla Etal, Maria V Humbert, Anna Freeman, Lisa Rydin, Kris Ostridge and 5 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Hannah BurkeFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Jodie AcklandFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Bastian R AngermannTranslational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Graham BelfieldTranslational Genomics, Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Doriana CelluraFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Damla EtalTranslational Genomics, Centre for Genomics Research, Discovery Sciences, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Maria V HumbertFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Anna FreemanFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Lisa RydinTranslational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Kris OstridgeFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Adam PlattTranslational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Alastair WatsonFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
C Mirella SpallutoFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Karl J StaplesFaculty of Medicine, University of Southampton, Southampton, United Kingdom.
Tom M A WilkinsonFaculty of Medicine, University of Southampton, Southampton, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality worldwide and currently lacks effective disease-modifying therapies. Extracellular vesicles (EVs) are key mediators of intercellular communication and transport biologically active cargo, including microRNAs (miRNAs). We previously identified 8 differentially expressed EV miRNA (miR-223-3p, miR-2110, miR-182-5p, miR-200b-5p, miR-625-3p, miR-204-5p, miR-138-5p and miR-338-3p) that were differentially expressed in individuals with COPD compared with healthy volunteer ex-smoker controls (HV-ES). This study aimed to identify miRNA-mRNA interactions in diseased lung epithelium that may contribute to COPD pathogenesis. Methods: Gene expression was quantified by RNA sequencing of epithelial brushings obtained from 24 subjects with COPD and 20 HV-ES. Results: A total of 191 genes were differentially expressed in epithelial brushings from subjects with COPD compared with HV-ES. Discussion: These findings highlight a potential role for EV-derived miRNA-mRNA regulatory networks in COPD pathogenesis, with miR-182-5p emerging as a putative regulator within this network. While exploratory analyses suggested possible associations with metabolic and immune-related pathways, these did not withstand multiple testing correction and should therefore be interpreted as hypothesis-generating. These findings support further mechanistic investigation of EV-derived miRNA-mRNA regulatory networks in COPD and may help inform future translational studies exploring their biological relevance.

Indexed as

extracellular vesiclesgene expression profilinggene expression regulationgene regulatory networkslung diseases, obstructivemicroRNAsmiR-182-5ppulmonary disease, chronic obstructive

Identifiers

PMID42440629
PMCPMC13333699

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.